Search

Search Results

43 results found. Results per page: [ 20 ] [ 40 ] [ 60 ] [ 80 ] [ 100 ] [ 200 ] [ 300 ]

Sort by: [ Publication Date ] [ Score ]

Direction: [ Desc ] [ Asc ]

Year of publication: [ 2026 ] [ 2025 ] [ 2024 ] [ 2023 ] [ 2022 ] [ 2021 ] [ 2020 ] [ 2019 ] [ 2018 ] [ 2017 ] [ 2016 ] [ 2015 ] [ 2014 ] [ 2013 ] [ 2012 ] [ 2011 ] [ 2010 ] [ 2009 ] [ Any ]

Page: 123 of 3

• EditorialVolume 9, Issue 6pp 1475-1476

  BET-inhibitors as sensitizers for BH3-mimetics

  Relevance score: 0.00

  Chiaki Tsuge Ishida, Georg Karpel-Massler, Markus D. Siegelin

  Keywords: Bromodomain Extraterminal domain proteins inhibitors, BH3-mimetics, drug combination therapies, cell death, cancer

  Published in Aging on June 26, 2017

• EditorialVolume 7, Issue 12pp 1030-1031

  TOR-inhibitors as gero-suppressors

  Relevance score: 0.00

  Mikhail Nikiforov

  Keywords: mTOR, Rapamycin, mTOR inhibitors, gero-suppression

  Published in Aging on December 30, 2015

• Research PaperVolume 15, Issue 24pp 15025-15049

  The efficacy of immune checkpoint inhibitors is limited in elderly NSCLC: a retrospective efficacy study and meta-analysis

  Relevance score: 0.00

  Jiaxin Yin, Yuxiao Song, Yang Fu, Wang Jun, Jiazhuo Tang, Zhimin Zhang, Qibin Song, Bicheng Zhang

  Keywords: immune checkpoint inhibitors, non-small cell lung cancer, age, elderly, meta-analysis

  Published in Aging on December 19, 2023

  Show abstract
• Research PaperVolume 15, Issue 17pp 8770-8781

  Prognostic value of lactate dehydrogenase in patients with uveal melanoma treated with immune checkpoint inhibition

  Relevance score: 0.00

  Xiaocui Liang, Shan Zhou, Zefeng Xiao

  Keywords: immune checkpoint inhibitors, uveal melanoma, lactate dehydrogenase, prognosis

  Published in Aging on September 5, 2023

  Show abstract
• Research PaperVolume 15, Issue 16pp 8204-8219

  PTPRD mutation is a prognostic biomarker for sensitivity to ICIs treatment in advanced non-small cell lung cancer

  Relevance score: 0.00

  Zhixuan Ren, Li Wang, Chaohui Leng

  Keywords: NSCLC, PTPRD, immune checkpoint inhibitors, nomogram, TCGA

  Published in Aging on August 18, 2023

  Show abstract
• Research PaperVolume 13, Issue 24pp 25920-25930

  LDH-A inhibitors as remedies to enhance the anticancer effects of PARP inhibitors in ovarian cancer cells

  Relevance score: 0.00

  Jiangdong Xiang, Lina Zhou, Yinyan He, Sufang Wu

  Keywords: LDH-A, PARP inhibitors, BRCA1, ovarian cancer, proliferation

  Published in Aging on December 16, 2021

  Show abstract
• Research PaperVolume 13, Issue 9pp 12748-12765

  The different hypoglycemic effects between East Asian and non-Asian type 2 diabetes patients when treated with SGLT-2 inhibitors as an add-on treatment for metformin: a systematic review and meta-analysis of randomized controlled trials

  Relevance score: 0.00

  Xianzhi Li, Qianping Zhang, Xiaojun Zhou, Siyi Guo, Shan Jiang, Yuhan Zhang, Ruzhen Zhang, Jianjun Dong, Lin Liao

  Keywords: SGLT-2 inhibitors, metformin, Asian, type 2 diabetes, randomized controlled trial, meta-analysis

  Published in Aging on May 11, 2021

  Show abstract
• Research PaperVolume 12, Issue 24pp 25101-25119

  Could microtubule inhibitors be the best choice of therapy in gastric cancer with high immune activity: mutant DYNC1H1 as a biomarker

  Relevance score: 0.00

  Jin Bai, BoWen Yang, Ruichuan Shi, Xinye Shao, Yujing Yang, Fang Wang, Jiawen Xiao, Xiujuan Qu, Yunpeng Liu, Ye Zhang, Zhi Li

  Keywords: immune checkpoint blockade, microtubule inhibitors, mutation, DYNC1H1, gastric cancer

  Published in Aging on November 20, 2020

  Show abstract
• Research PaperVolume 8, Issue 12pp 3535-3551

  Gerosuppression by pan-mTOR inhibitors

  Relevance score: 0.00

  Olga V. Leontieva, Mikhail V. Blagosklonny

  Keywords: dual mTORC1/C2 inhibitors, rapalogs, sirolimus, aging, cancer, senescence

  Published in Aging on December 30, 2016

  Show abstract
• EditorialVolume 7, Issue 12pp 1026-1027

  Fasting plus tyrosine kinase inhibitors in cancer

  Relevance score: 0.00

  Irene Caffa, Valter D. Longo, Alessio Nencioni

  Keywords: cancer, fasting, tyrosine kinase inhibitors, MAPK signaling, molecularly, targeted therapy

  Published in Aging on December 6, 2015

• EditorialVolume 7, Issue 10pp 748-749

  Antagonizing Bcl-2′s BH4 domain in cancer

  Relevance score: 0.00

  Tamara Vervloessem, Rita La Rovere, Geert Bultynck

  Keywords: Bcl-2 inhibitors, BH4 domain, apoptosis, anticancer, peptides, small molecules

  Published in Aging on October 22, 2015

• Research PaperVolume 15, Issue 16pp 7997-8012

  HYDIN mutation status as a potential predictor of immune checkpoint inhibitor efficacy in melanoma

  Relevance score: 0.00

  Liu Li, Kuang Tianrui, Li Chunlei, Qiu Zhendong, Chen Xiaoyan, Deng Wenhong

  Keywords: HYDIN, immune checkpoint inhibitors, melanoma, biomarker, prognosis

  Published in Aging on August 17, 2023

  Show abstract
• Research PaperVolume 15, Issue 6pp 2237-2274

  A network meta-analysis of the efficacy of hypoxia-inducible factor prolyl-hydroxylase inhibitors in dialysis chronic kidney disease

  Relevance score: 0.00

  Jun Chen, Xinyang Shou, Yanyan Xu, Lie Jin, Chaoyong Zhu, Xiaolan Ye, Ziwei Mei, Peipei Chen

  Keywords: hypoxia-inducible factor prolyl-hydroxylase inhibitors, erythropoiesis-stimulating agents, anemia, chronic kidney disease, dialysis

  Published in Aging on March 27, 2023

  Show abstract
• EditorialVolume 11, Issue 16pp 5866-5867

  The anti-inflammatory effects of SGLT inhibitors

  Relevance score: 0.00

  Álvaro García-Ropero, Carlos G Santos-Gallego, Juan J. Badimon

  Keywords: diabetes mellitus, cardiovascular mortality, inflammation, SGLT inhibitors, empagliflozin, anti-inflammatory effects

  Published in Aging on August 25, 2019

• Research PaperVolume 3, Issue 9pp 852-872

  Structure-based development of novel sirtuin inhibitors

  Relevance score: 0.00

  Christine Schlicker, Gina Boanca, Mahadevan Lakshminarasimhan, Clemens Steegborn

  Keywords: Sirtuins, docking, Sirt2, inhibitors, isoform-specific, structure-based drug development, aging-related diseases

  Published in Aging on September 20, 2011

  Show abstract
• Research PaperVolume 16, Issue 16pp 11994-12007

  Association between dipeptidyl peptidase-4 inhibitor use and risk of Parkinson’s disease among patients with diabetes mellitus: a retrospective cohort study

  Relevance score: 0.00

  Kuang-Hua Huang, Yih Yang, Shuo-Yan Gau, Tung-Han Tsai, Chien-Ying Lee

  Keywords: Parkinson disease, DPP-4 inhibitors, diabetes mellitus, defined daily dose

  Published in Aging on August 22, 2024

  Show abstract
• Research PaperVolume 16, Issue 6pp 5354-5369

  Cancer cachexia reduces the efficacy of immune checkpoint inhibitors in cancer patients

  Relevance score: 0.00

  Yean Yu, Li Yan, Tianhui Huang, Zhenfu Wu, Juan Liu

  Keywords: cachexia, immune checkpoint inhibitors, cancers, non-small cell lung cancer

  Published in Aging on March 11, 2024

  Show abstract
• Research PaperVolume 15, Issue 24pp 15473-15488

  Efficacy and safety analysis of a HER2-targeting antibody-drug conjugate combined with immune checkpoint inhibitors in solid tumors: a real-world study

  Relevance score: 0.00

  Yi-Xin Zhou, Jia-Ling Wang, Xiao-Li Mu, Ya-Juan Zhu, Ye Chen, Ji-Yan Liu

  Keywords: Disitamab Vedotin, immune checkpoint inhibitors, HER2, solid tumors

  Published in Aging on December 22, 2023

  Show abstract
• Research PaperVolume 13, Issue 11pp 15336-15352

  Pharmacological targeting of TNS3 with histone deacetylase inhibitor as a therapeutic strategy in esophageal squamous cell carcinoma

  Relevance score: 0.00

  Yang Shi, Zheng Xiang, Huiyu Yang, Suliman Khan, Ruizhe Li, Siran Zhou, Saif Ullah, Jiyu Zhang, Bingrong Liu

  Keywords: histone acetylation, histone deacetylase inhibitors, LMK-235, esophageal squamous cell carcinoma, tensin-3

  Published in Aging on May 28, 2021

  Show abstract
• Research PaperVolume 12, Issue 11pp 10663-10675

  Association between immune-related adverse events and efficacy of PD-1 inhibitors in Chinese patients with advanced melanoma

  Relevance score: 0.00

  Jing-Jing Zhao, Xi-Zhi Wen, Ya Ding, Dan-Dan Li, Bao-Yan Zhu, Jing-Jing Li, De-Sheng Weng, Xing Zhang, Xiao-Shi Zhang

  Keywords: immune-related adverse events, PD-1 inhibitor, immune checkpoint inhibitors, advanced melanoma, Chinese patients

  Published in Aging on June 8, 2020

  Show abstract